(Q46374039)

21 December 2017

title

Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy (English)

1 reference

21 December 2017

author name string

Philip D Hardt

series ordinal

1

1 reference

21 December 2017

Nils Ewald

series ordinal

2

1 reference

21 December 2017

publication date

1 September 2008

1 reference

21 December 2017

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

published in

1 reference

21 December 2017

volume

8

1 reference

21 December 2017

issue

5

1 reference

21 December 2017

page(s)

579-585

1 reference

21 December 2017

Pyruvate kinase type M2 and its role in tumor growth and spreading

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Plasma concentrations of tumour dimeric pyruvate kinase are increased in patients with chronic cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Tumour M2-pyruvate kinase: a gastrointestinal cancer marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Diagnostic and prognostic value of plasma tumor M2 pyruvate kinase in periampullary cancer: evidence for a novel biological marker of adverse prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Comparison of different stool tests for the detection of cancer of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Fecal blood levels in health and disease. A study using HemoQuant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Randomised study of screening for colorectal cancer with faecal-occult-blood test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Colorectal cancer screening: prospects for molecular stool analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Glycolysis—one of the keys to cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Double role of pyruvate kinase type M2 in the regulation of phosphometabolite pools

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Tumor M2-Pyruvate Kinase as Tumor Marker in Exocrine Pancreatic Cancer A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.579

21 January 2018

Identifiers

DOI

10.1586/14737159.8.5.579

1 reference

21 December 2017

PubMed ID

18785806

1 reference

21 December 2017